奥美拉唑联合奥曲肽治疗非静脉曲张性上消化道出血

目的 探讨奥美拉唑联合奥曲肽联合治疗非静脉曲张性上消化道出血的临床疗效及安全性.方法 将96例非静脉曲张性上消化道出血患者,随机分为治疗组和对照组,每组各48例.两组患者均给予补液、输血、营养支持等基础治疗.对照组单纯服用奥美拉唑,治疗组在此基础上加用奥曲肽,疗程为3d.观察患者生命体征,并记录24h尿量,72 h内再出血例数及药物的不良反应.结果 治疗组总有效率为91.7％,高于对照组的72.9％（x2=5.79,P＜0.05）；治疗组的止血时间、输血量、再出血率均优于对照组（t=7.69,9.91,x2=4.80,均P＜0.05）；两组患者均未见明显不良反应.结论 奥美拉唑联合奥曲肽治疗非静脉曲张性上消化道出血优于单用奥美拉唑,安全高效,且可减少再出血.

Clinical observation on the effect of omeprazole combined with octreotide in treatment of patients with nonvariceal upper gastrointestinal hemorrhage

Objective To explore the clinical effect of omeprazole combined with octreotide in treatment of patients with non-variceal upper gastrointestinal hemorrhage.Methods 96 patients with non-variceal upper gastrointestinal hemorrhage were randomly divided into two groups.All the cases were received basic treatment of fluid infusion,transfusion and nutritional support.The control group( n =48) was treated with omeprazole alone,and the treatment group(n =48) was treated with omeprazole and octreotide.The course of treatment was 3 days.The vital signs,24h urine output,the number of cases of rebleeding in 72 h and adverse drug reactions was observed and recorded.Results The total effective rate in treatment group and control group was 91.7％ and 72.9％,respectively.The difference between the two groups was statistically significant( x2 =5.79,P ＜0.05 ).The time of hemostasis and blood transfusion volume in treatment group were significantly less than those in control group(t =7.69,9.91,all P ＜0.05).The rebleeding rates after 72 hours of hemostasis between the two groups(8.3％ vs 25.0％ ) was significantly different ( x2 =4.80,P ＜ 0.05 ).In the course of treatment,the side effects weren' t found in both groups.Conclusion Omeprazole combined with octreotide was more effective and safe than omeprazole alone in fast stopping bleeding and reducing rebleeding rate.